19 November 2024
BEXIMCO PHARMACEUTICALS
LIMITED
AGM
Notification
Beximco Pharmaceuticals Limited
("Beximco Pharma", "BPL" or "the Company"; AIM Symbol: BXP, LEI
No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of
generic pharmaceutical products and active pharmaceutical
ingredients, today announces that the forty-eighth Annual General
Meeting of Shareholders (AGM) of Beximco Pharma will be held on
Sunday, the 29th December, 2024 at 10.30 am Bangladesh time under
the Virtual Platform through https://bxpharma.bdvirtualagm.com
to transact the following business:
AGENDA
ORDINARY BUSINESS:
1. To receive, consider and adopt the Audited
Financial Statements of the Company for the year ended on 30th
June, 2024 together with reports of the Auditors and the Directors
thereon.
2. To declare 40% cash dividend as recommended by
the Board of Directors.
3. To elect Directors.
4. To approve the appointment of Managing
Director.
5. To approve the re-appointment of Independent
Director.
6. To appoint Statutory Auditors for the year
2024-25 and to fix their remuneration.
7. To appoint Corporate Governance Compliance
Auditors for the year 2024-25 and to fix their
remuneration.
SPECIAL BUSINESS:
To pass Special Resolutions to
change the name of the Company from "Beximco Pharmaceuticals
Limited" to "Beximco Pharmaceuticals PLC" as per the provision of
the Companies Act, 1994 (as amended in 2020) and to effect the
change of the name in the relevant Clauses of the Memorandum and
Articles of Association of the Company.
The draft of the Special Resolutions
proposed to be passed is given below:
"Resolved that the name of the
Company be changed from Beximco Pharmaceuticals Limited to Beximco
Pharmaceuticals PLC and the new name of the Company be incorporated
in the Memorandum and Articles of Association of the Company and an
amended copy of the Memorandum and Articles of Association of the
Company be and is hereby adopted and the same be filed with the
Registrar of Joint Stock Companies, Dhaka, Bangladesh for
record."
|
Dated: November 18, 2024
|
By order
of the Board,
Sd/-
(MOHAMMAD ASAD ULLAH,
FCS)
EXECUTIVE
DIRECTOR & COMPANY SECRETARY
|
NOTES:
(1)
The Shareholders whose names appear in the Share Register of the
Company or in the Depository Register on the record date i.e. 25
November, 2024 will be entitled to receive the dividend and to
attend the Annual General Meeting.
(2)
A Member entitled to attend and vote at the General Meeting may
appoint a Proxy to attend and vote in his/her stead. The Proxy
Form, duly stamped, must be deposited at the Share Department of
the Company at BEL Tower, Level-2, 19 Dhanmondi, Road No.1,
Dhaka-1205, no later than 48 hours before the time fixed for the
meeting.
(3)
Annual Report for the year 2023-24 will be sent through e-mail
address of the valued Shareholders and will be available in the
Website of the Company at: www.beximcopharma.com.
(4)
The valued Shareholders will join the Virtual AGM through the
Link https://bxpharma.bdvirtualagm.com.
The Shareholders will be able to submit their questions/comments
and vote electronically 24 (Twenty-four) hours before commencement
of the AGM and also during the AGM. For logging into the system,
the Shareholders need to put their 16-digit Beneficial Owner (BO)
ID/Folio Number and other credential as proof by visiting the said
Link.
(5)
We encourage the Shareholders to login into the system prior to the
meeting. Please allow ample time to login and establish your
connectivity. For any IT related guidance, Shareholders may contact
vide email : monir@beximco.net
or mazibur@beximco.net.